Nutex Health Inc [NASDAQ: NUTX] gained 3.11% on the last trading session, reaching $0.09 price per share at the time. The company report on March 28, 2024 at 6:56 PM that NUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS.
TOTAL REVENUE OF $247.6 MILLION FOR THE YEAR ENDED 2023 VS $219.3 MILLION IN 2022, AN INCREASE OF 13%.
HOSPITAL DIVISION OPERATING INCOME OF $36.3 MILLION FOR YEAR ENDED 2023 VS $15.0 MILLION IN 2022, AN INCREASE OF 142%.
If compared to the average trading volume of 1.82M shares, NUTX reached a trading volume of 2729019 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Nutex Health Inc [NUTX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NUTX shares is $1.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NUTX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Northland Capital have made an estimate for Nutex Health Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on February 22, 2023.
The Average True Range (ATR) for Nutex Health Inc is set at 0.01, with the Price to Sales ratio for NUTX stock in the period of the last 12 months amounting to 0.27. The Price to Book ratio for the last quarter was 0.99, with the Price to Cash per share for the same quarter was set at 0.03.
Trading performance analysis for NUTX stock
Nutex Health Inc [NUTX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -12.16. With this latest performance, NUTX shares dropped by -16.81% in over the last four-week period, additionally sinking by -54.24% over the last 6 months – not to mention a drop of -90.88% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NUTX stock in for the last two-week period is set at 30.93, with the RSI for the last a single of trading hit 28.95, and the three-weeks RSI is set at 32.79 for Nutex Health Inc [NUTX]. The present Moving Average for the last 50 days of trading for this stock 0.1104, while it was recorded at 0.0922 for the last single week of trading, and 0.2302 for the last 200 days.
Nutex Health Inc [NUTX]: A deeper dive into fundamental analysis
Nutex Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.50 and a Current Ratio set at 1.56.
Nutex Health Inc [NUTX]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Nutex Health Inc posted -0.01/share EPS, while the average EPS was predicted by analysts to be reported at -0.01/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NUTX.
An analysis of Institutional ownership at Nutex Health Inc [NUTX]
The top three institutional holders of NUTX stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in NUTX stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in NUTX stock with ownership which is approximately 5.8386%.
